6258
R. Das, D. Chakraborty / Tetrahedron Letters 51 (2010) 6255–6258
5. (a) Salas, M.; Ward, A.; Caro, J. B. M. C. Gastroenterology 2002, 2, 17; (b) Spencer,
C. M.; Faulds, D. Drugs 2000, 60, 321–329.
18. Stanger, K. J.; Wiench, J. W.; Pruski, M.; Espenson, J. H.; Kraus, G. A.; Angelici, R.
J. J. Mol. Catal. A 2006, 243, 158–169.
6. Perez-Giraldo, C.; Cruz-Villalon, G.; Sanchez-Silos, R.; Martinez-Rubio, R.;
Blanco, M. T.; Gomez-Garcia, A. C. J. Appl. Microbiol. 2003, 95, 709–711.
7. Merino, G.; Molina, A. J.; Garcia, J. L.; Pulido, M. M.; Prieto, J. G.; Alverez, A. I. J.
Pharm. Pharmacol. 2003, 55, 757–764.
19. (a) Egami, H.; Katsuk, T. J. Am. Chem. Soc. 2007, 129, 8940–8941; (b) Baciocchi,
E.; Gerini, M. F.; Lapi, A. J. Org. Chem. 2004, 69, 3586–3589; (c) Legros, J.; Bolm,
C. Angew. Chem., Int. Ed. 2003, 42, 5487–5489; (d) Marques, A.; Marin, M.;
Ruasse, M. F. J. Org. Chem. 2001, 66, 7588–7595.
8. Kotelanski, B.; Grozmann, R. J.; Cohn, J. N. Clin. Pharmacol. Ther. 1973, 14, 427–
433.
9. Scimied, R.; Wang, G. X.; Korth, M. Circ. Res. 1991, 68, 597–604.
10. Lechin, F.; Van der Dijis, B.; Pardey-Maldonado, B.; John, E.; Jimenez, V.; Orozco,
B.; Baez, S.; Lechin, M. E. J. Med. 2000, 31, 333–361.
20. (a) Barker, J. E.; Ren, T. Tetrahedron Lett. 2005, 46, 6805–6808; (b) Xie, F.; Fu, Z.
H.; Zhong, S.; Ye, Z. P.; Zhou, X. P.; Liu, F. L.; Rong, C. Y.; Mao, L. Q.; Yin, D. L. J.
Mol. Catal. A 2009, 307, 93–97.
21. Iwamoto, M.; Tanaka, Y.; Hirosumi, J.; Kita, N.; Triwahyono, S. Microporous
Mesoporous Mater. 2001, 48, 271–277.
11. Padmanabhan, S.; Lavin, R. C.; Durant, G. J. Tetrahedron: Asymmetry 2000, 11,
3455–3457.
22. Conte, V.; Fabbianesi, F.; Floris, B.; Galloni, P.; Sordi, D.; Arends, I. C. W. E.;
Bonchio, M.; Rehder, D.; Bogdal, D. Pure Appl. Chem. 2009, 81, 1265–1277.
23. Shi, F.; Tse, M. K.; Kaiser, H. M.; Beller, M. Adv. Synth. Catal. 2007, 349, 2425–
2430.
24. (a) Chakraborty, D.; Gowda, R. R.; Malik, P. Tetrahedron Lett. 2009, 50, 6553–
6556; (b) Malik, P.; Chakraborty, D. Tetrahedron Lett. 2010, 51, 3521–3523.
25. Jayaseeli, A. M. I.; Rajagopal, S. J. Mol. Catal. A: Chem. 2009, 309, 103–110.
12. (a) Bagherzadeh, M.; Latifi, R.; Tahsini, L.; Amini, M. Catal. Commun. 2008, 10,
196–200; (b) Karimi, B.; Nezhad, M. G.; Clark, J. H. Org. Lett. 2005, 7, 625–628;
(c) Hajipour, A. R.; Ruoho, A. E. Sulfur Lett. 2003, 26, 83–87; (d) Bravo, A.; Dordi,
B.; Fontana, F.; Minisci, F. J. Org. Chem. 2001, 66, 3232–3234.
13. Venier, C. G.; Squires, T. G.; Chen, Y. Y.; Hussmann, G. P.; Shei, J. C.; Smith, B. F. J.
Org. Chem. 1982, 47, 3773–3774.
26. Typical experimental procedure: To
a stirred solution of CuBr2 (11.2 mg,
14. Gasparrini, F.; Giovannoli, M.; Maresca, L.; Natile, G.; Palmieri, G. Synth.
Commun. 1984, 14, 1111–1117.
15. Lakouraj, M. M.; Tajbakhsh, M.; Shirini, F.; Asady Tamani, M. V. Synth. Commun.
2005, 35, 775–784.
16. (a) Shukla, V. G.; Salgaonkar, P. D.; Akamanchi, K. G. J. Org. Chem. 2003, 68,
5422–5425; (b) Tohama, H.; Takizawa, S.; Watanabe, H.; Kita, Y. Tetrahedron
Lett. 1998, 39, 4547–4550; (c) Xia, M.; Chen, Z. C. Synth. Commun. 1997, 27,
1315–1320.
17. (a) Romanelli, G. P.; Bennardi, D. O.; Palermo, V.; Vázquez, P. G.; Tundo, P. Lett.
Org. Chem. 2007, 4, 544–549; (b) Trivedi, R.; Lalitha, P. Synth. Commun. 2006,
36, 3777–3782; (c) Di Furia, F.; Modena, G.; Curci, R. Tetrahedron Lett. 1976, 17,
4637–4638.
0.05 mmol) and sulfide/disulfide (1 mmol) in 2.5 mL MeCN was added 70% t-
BuOOH (water) (0.64 mL, 5 mmol). The reaction mixture was heated to reflux
and the progress was monitored by TLC until all sulfide/disulfide was found
consumed. After completion, MeCN was evaporated and the crude mixture was
washed with NaHCO3 and extracted with ethyl acetate. The ethyl acetate was
evaporated followed by flash column purification to obtain the pure sulfoxides.
The product was characterized using 1H, 13C NMR spectroscopy and ESI-MS.
The data were found to be in accordance with the literature (see
Supplementary data).